Login / Signup

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.

Katherine AdamsJillian P RhoadsDiya SurieManjusha GaglaniAdit A GindeTresa McNealH Keipp TalbotJonathan D CaseyAnne ZepeskiNathan I ShapiroKevin W GibbsD Clark FilesDavid N HagerAnne E FroschMatthew C ExlineAmira MohamedNicholas J JohnsonJay S SteingrubIthan D PeltanSamuel M BrownEmily T MartinAdam S LauringAkram KhanLaurence W BusseAbhijit DuggalJennifer G WilsonSteven Y ChangChristopher MallowJennie H KwonJames D ChappellNatasha HalasaCarlos G GrijalvaChristopher J LindsellSandra N LesterNatalie J ThornburgSoHee ParkMeredith L McMorrowManish M PatelMark W TenfordeWesley H Selfnull null
Published in: BMJ (Clinical research ed.) (2022)
This article is a living test negative design study that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication.
Keyphrases
  • coronavirus disease
  • randomized controlled trial
  • sars cov